Tanaka, K.; Sugiyama, H.; Morinaga, H.; Kitagawa, M.; Kano, Y.; Onishi, Y.; Mise, K.; Tanabe, K.; Uchida, H.A.; Wada, J.
Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy. J. Clin. Med. 2023, 12, 2023.
https://doi.org/10.3390/jcm12052023
AMA Style
Tanaka K, Sugiyama H, Morinaga H, Kitagawa M, Kano Y, Onishi Y, Mise K, Tanabe K, Uchida HA, Wada J.
Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy. Journal of Clinical Medicine. 2023; 12(5):2023.
https://doi.org/10.3390/jcm12052023
Chicago/Turabian Style
Tanaka, Keiko, Hitoshi Sugiyama, Hiroshi Morinaga, Masashi Kitagawa, Yuzuki Kano, Yasuhiro Onishi, Koki Mise, Katsuyuki Tanabe, Haruhito A. Uchida, and Jun Wada.
2023. "Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy" Journal of Clinical Medicine 12, no. 5: 2023.
https://doi.org/10.3390/jcm12052023
APA Style
Tanaka, K., Sugiyama, H., Morinaga, H., Kitagawa, M., Kano, Y., Onishi, Y., Mise, K., Tanabe, K., Uchida, H. A., & Wada, J.
(2023). Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy. Journal of Clinical Medicine, 12(5), 2023.
https://doi.org/10.3390/jcm12052023